Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
Check out this week's top-performing mid-cap stocks, including Akero Therapeutics' remarkable 106.57% surge following ...
Robert Kiyosaki Predicts Gold, Silver, Bitcoin Crash Over Trump's Tariffs—Says It's A Buying Moment
Noted investor and author Robert Kiyosaki has forecast a potential Bitcoin (CRYPTO: BTC) crash, which he sees as a chance to amass more wealth< ...
'The Economics Of AI Are About To Change Completely': Why OpenAI's o3 Could Reshape The Industry — Costing Up To $3000 Per Query
OpenAI, valued at $157 billion, may charge up to $2,000 monthly for full access to o3, according to The Economist, which cited New Street Research analyst Pierre Ferragu. Even the company’s current ...